rivaroxaban tablet
bayer inc - rivaroxaban - tablet - 2.5mg - rivaroxaban 2.5mg - direct factor xa inhibitors
rivaroxaban sandoz 2.5 mg film-coat. tabl.
sandoz sa-nv - rivaroxaban 2,5 mg - film-coated tablet - 2,5 mg - rivaroxaban 2.5 mg - rivaroxaban
rivaroxaban sandoz gmbh 2.5 mg film-coat. tabl.
sandoz gmbh - rivaroxaban 2,5 mg - film-coated tablet - 2,5 mg - rivaroxaban 2.5 mg - rivaroxaban
rivaroxaban sandoz gmbh 10 mg film-coat. tabl.
sandoz gmbh - rivaroxaban 10 mg - film-coated tablet - 10 mg - rivaroxaban 10 mg - rivaroxaban
rivaroxaban sandoz gmbh 15 mg film-coat. tabl.
sandoz gmbh - rivaroxaban 15 mg - film-coated tablet - 15 mg - rivaroxaban 15 mg - rivaroxaban
rivaroxaban sandoz gmbh 20 mg film-coat. tabl.
sandoz gmbh - rivaroxaban 20 mg - film-coated tablet - 20 mg - rivaroxaban 20 mg - rivaroxaban
rivaroxaban sandoz gmbh 15 mg - 20 mg film-coat. tabl.
sandoz gmbh - rivaroxaban 15 mg (red tablet 15 mg); rivaroxaban 20 mg (brown-red tablet 20 mg) - film-coated tablet - 15 mg + 20 mg - rivaroxaban 15 mg; rivaroxaban 20 mg - rivaroxaban
rivaroxaban s.k. 10 mg
k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - film coated tablets - rivaroxaban 10 mg - rivaroxaban - prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. prevention of recurrent deep vein thrombosis (dvt) and pulmonary embolism (pe), in adults (following completion of at least 6 months therapy for dvt or pe).
rivaroxaban s.k. 15 mg
k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - film coated tablets - rivaroxaban 15 mg - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults
rivaroxaban s.k. 20 mg
k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - film coated tablets - rivaroxaban 20 mg - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults